CAMP4 Therapeutics Corporation (CAMP)
(Delayed Data from NSDQ)
$2.28 USD
-0.22 (-8.80%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.27 -0.01 (-0.44%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Return on Equity (TTM)
CalAmp Corp.'s return on equity, or ROE, is -51.60% compared to the ROE of the Electronics - Miscellaneous Components industry of 7.81%. While this shows that CAMP has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
CAMP 2.28 -0.22(-8.80%)
Will CAMP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CAMP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAMP
Is CAMP preparing to trend higher? 1,2,3 Pullback Bullish shows up after plummeting 8.8%
Calm After Storm appears for CAMP after 3.47% move
CAMP forms 1,2,3 Pullback Bullish on September 18
Promising Prospects for CAMP4 Therapeutics: Buy Rating Affirmed Amid Advancements in CMP-SYNGAP-01 Program and Strong Investor Confidence
CAMP forms Hammer Candlestick on September 16